Nucliq Biologics
PrivateLast Round
Seed
Apr 24, 2025
Total Funding Raised
$760,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Nucliq Biologics is a biotechnology company that develops microbiome-based personalized therapeutics, diagnostics, and at-home testing kits using microbiome science and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical Devices, D2C Brands
Business Model
B2C
Customer Profile
Hardware Sales, Data as a Service, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucliq Biologics Comparables
Compare Nucliq Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Jona | 82% | |
| Biohm Technologies | 81% | |
| Tiny Health | 80% |
Nucliq Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 24, 2025 | ||||
| Grant | Jan 17, 2024 | ||||
| Grant | Jun 16, 2020 |
Nucliq Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Government of Newfoundland and Labrador | Grant |
| Memorial Centre for Entrepreneurship | Grant |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Atlantic Canada Opportunities Agency | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased from 0 to 4, representing 29% of headcount.
- Jul 5, 2025
Monthly visitors increased 67% MoM.
Nucliq Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nucliq Biologics's valuation, stock price, and market status.
Is Nucliq Biologics a public or private company?
Nucliq Biologics is a private company.
What is the current stock price of Nucliq Biologics?
Nucliq Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Nucliq Biologics worth (valuation)?
Valuation information for Nucliq Biologics is not publicly available.
Can I buy Nucliq Biologics stock?
Nucliq Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nucliq Biologics's last funding round?
Nucliq Biologics's most recent funding round was Seed on April 24, 2025.
Who are the main investors in Nucliq Biologics?
Key investors in Nucliq Biologics include Government of Newfoundland and Labrador, Memorial Centre for Entrepreneurship, National Research Council Canada Industrial Research Assistance Program, Atlantic Canada Opportunities Agency.
Will Nucliq Biologics IPO soon?
No public IPO plans have been announced for Nucliq Biologics.
How can I track Nucliq Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nucliq Biologics's secondary market activity and sign up for updates.